Back to User profile » Professor Reynold Panettieri Jr

Papers published by Professor Reynold Panettieri Jr:


Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types

Panettieri R Jr, Lugogo N, Corren J, Ambrose CS

Journal of Asthma and Allergy 2024, 17:219-236

Published Date: 19 March 2024

Effect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease in the FULFIL Trial

Panettieri Jr RA, Camargo CA Jr, Cheema T, El Bayadi SG, Fiel S, Vila TM, Jain RG, Midwinter D, Thomashow B, Ludwig-Sengpiel A, Lipson DA

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2043-2052

Published Date: 1 September 2022

Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation

Hanania NA, Maspero JF, Halpin DM, Jackson DJ, Panettieri RA, Castro M, Domingo C, Daizadeh N, Gall R, Jacob-Nara JA, Ortiz B, Djandji M, Rowe PJ, Deniz Y

Journal of Asthma and Allergy 2022, 15:851-854

Published Date: 28 June 2022

The CHRONICLE Study of US Adults with Subspecialist-Treated Severe Asthma: Objectives, Design, and Initial Results

Ambrose CS, Chipps BE, Moore WC, Soong W, Trevor J, Ledford DK, Carr WW, Lugogo N, Trudo F, Tran TN, Panettieri RA Jr

Pragmatic and Observational Research 2020, 11:77-90

Published Date: 16 July 2020

Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA)

Panettieri RA Jr, Welte T, Shenoy KV, Korn S, Jandl M, Kerwin EM, Feijoo R, Barker P, Olsson RF, Martin UJ

Journal of Asthma and Allergy 2020, 13:115-126

Published Date: 17 February 2020